Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03079843 · ClinicalTrials.gov registry record · NA

Particulate Matter, Blood Pressure, and the Sympathetic Nervous System

A NA study of Air Pollution, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03079843: Completed NA study of Air Pollution, sponsored by University of Michigan.

NCT03079843 is a NA study of Air Pollution that has completed, run by University of Michigan. The registered enrollment target is 50 participants, roughly in line with the 55-participant average among 7 other Air Pollution trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03079843, a NA study of Air Pollution, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Healthy volunteers will be exposed to ambient air near a roadway under the conditions of with and without a facemask and their responses will be evaluated.

Primary Outcome

increased blood pressure as a result of air pollution exposure without the mask.

Conditions Studied

Interventions

  • OTHER exposure to particulate matter with N 95 facemask
  • OTHER exposure to particulate matter with no face mask

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-04-07
Est. Completion 2019-04-30
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03079843 record still lists

NCT03079843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, roughly in line with the 55-participant average among 7 other Air Pollution trials with a reported enrollment target.

The record links to 1 condition, with Air Pollution appearing as the primary indexed condition, and to 2 interventions - of which exposure to particulate matter with N 95 facemask is the first listed.

NCT03079843 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03079843 about?

NCT03079843 is a clinical study titled "Particulate Matter, Blood Pressure, and the Sympathetic Nervous System". Healthy volunteers will be exposed to ambient air near a roadway under the conditions of with and without a facemask and their responses will be evaluated.

What is the current status of trial NCT03079843?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-07. Estimated completion is 2019-04-30.

What conditions does trial NCT03079843 study?

This clinical trial studies the following conditions: Air Pollution.

What interventions are being tested in trial NCT03079843?

The interventions under investigation include: exposure to particulate matter with N 95 facemask (OTHER), exposure to particulate matter with no face mask (OTHER).

Who is sponsoring clinical trial NCT03079843?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03079843 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Air Pollution

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03079843, the US trial registry maintained by the National Library of Medicine. NCT03079843 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.